BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 33935281)

  • 1. ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4.
    Liu J; Cao F; Li X; Zhang L; Liu Z; Li X; Lin J; Han C
    Cell Death Dis; 2021 May; 12(5):438. PubMed ID: 33935281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ITIH5, as a predictor of prognosis and immunotherapy response for P53-like bladder cancer, is related to cell proliferation and invasion.
    Peng K; Ding D; Wang N; Du T; Wang L; Duan X
    Mol Omics; 2023 Oct; 19(9):714-725. PubMed ID: 37431189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the adaptation to ER stress by KLF4 facilitates melanoma cell metastasis via upregulating NUCB2 expression.
    Zhang D; Lin J; Chao Y; Zhang L; Jin L; Li N; He R; Ma B; Zhao W; Han C
    J Exp Clin Cancer Res; 2018 Jul; 37(1):176. PubMed ID: 30055641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
    Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
    Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.
    Sasaki K; Kurahara H; Young ED; Natsugoe S; Ijichi A; Iwakuma T; Welch DR
    Clin Exp Metastasis; 2017 Apr; 34(3-4):229-239. PubMed ID: 28289921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITIH5 mediates epigenetic reprogramming of breast cancer cells.
    Rose M; Kloten V; Noetzel E; Gola L; Ehling J; Heide T; Meurer SK; Gaiko-Shcherbak A; Sechi AS; Huth S; Weiskirchen R; Klaas O; Antonopoulos W; Lin Q; Wagner W; Veeck J; Gremse F; Steitz J; Knüchel R; Dahl E
    Mol Cancer; 2017 Feb; 16(1):44. PubMed ID: 28231808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5.
    Young ED; Manley SJ; Beadnell TC; Shearin AE; Sasaki K; Zimmerman R; Kauffman E; Vivian CJ; Parasuram A; Iwakuma T; Grandgenett PM; Hollingsworth MA; O'Neil M; Welch DR
    Br J Cancer; 2021 Jan; 124(1):166-175. PubMed ID: 33024269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis combined with functional genomics approach identifies ITIH5 as tumor suppressor gene in cervical carcinogenesis.
    Dittmann J; Ziegfeld A; Jansen L; Gajda M; Kloten V; Dahl E; Runnebaum IB; Dürst M; Backsch C
    Mol Carcinog; 2017 Jun; 56(6):1578-1589. PubMed ID: 28059468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-α-trypsin inhibitor heavy chain 5 (ITIH5) is overexpressed in inflammatory skin diseases and affects epidermal morphology in constitutive knockout mice and murine 3D skin models.
    Huth S; Heise R; Vetter-Kauczok CS; Skazik C; Marquardt Y; Czaja K; Knüchel R; Merk HF; Dahl E; Baron JM
    Exp Dermatol; 2015 Sep; 24(9):663-8. PubMed ID: 25809190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
    Zhu Z; Yu Z; Wang J; Zhou L; Zhang J; Yao B; Dou J; Qiu Z; Huang C
    Cell Physiol Biochem; 2018; 46(1):238-252. PubMed ID: 29587259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
    Mai C; Zhao JJ; Tang XF; Wang W; Pan K; Pan QZ; Zhang XF; Jiang SS; Zhao BW; Li YF; Xia JC; Zhou ZW
    Med Oncol; 2014 Jul; 31(7):53. PubMed ID: 24913813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Krüppel-like factor 4 promotes human osteosarcoma growth and metastasis via regulating CRYAB expression.
    Zhang L; Zhang L; Xia X; He S; He H; Zhao W
    Oncotarget; 2016 May; 7(21):30990-1000. PubMed ID: 27105535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.
    Rose M; Meurer SK; Kloten V; Weiskirchen R; Denecke B; Antonopoulos W; Deckert M; Knüchel R; Dahl E
    Mol Carcinog; 2018 Feb; 57(2):167-181. PubMed ID: 28940371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells.
    Rose M; Noetzel E; Kistermann J; Eschenbruch J; Rushrush S; Gan L; Knüchel R; Gaisa NT; Dahl E
    Cells; 2021 Apr; 10(5):. PubMed ID: 33924987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.
    Rose M; Gaisa NT; Antony P; Fiedler D; Heidenreich A; Otto W; Denzinger S; Bertz S; Hartmann A; Karl A; Knüchel R; Dahl E
    Carcinogenesis; 2014 Mar; 35(3):727-36. PubMed ID: 24265292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer.
    Himmelfarb M; Klopocki E; Grube S; Staub E; Klaman I; Hinzmann B; Kristiansen G; Rosenthal A; Dürst M; Dahl E
    Cancer Lett; 2004 Feb; 204(1):69-77. PubMed ID: 14744536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-α-Trypsin Inhibitor Heavy Chain 5 (ITIH5) Is a Natural Stabilizer of Hyaluronan That Modulates Biological Processes in the Skin.
    Huth S; Huth L; Marquardt Y; Fietkau K; Dahl E; Esser PR; Martin SF; Heise R; Merk HF; Baron JM
    Skin Pharmacol Physiol; 2020; 33(4):198-206. PubMed ID: 32799206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
    Riverso M; Montagnani V; Stecca B
    Oncogene; 2017 Jun; 36(23):3322-3333. PubMed ID: 28068326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
    Dötsch MM; Kloten V; Schlensog M; Heide T; Braunschweig T; Veeck J; Petersen I; Knüchel R; Dahl E
    Epigenetics; 2015; 10(10):903-12. PubMed ID: 26252352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.